CoChat

A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis

Badorrek, P., Dick, M., Schauerte, A., Hecker, H., Murdoch, R., Luettig, B., Hohlfeld, J.M., Krug, N. · 2009 · Int. Journal of Clinical Pharmacology and Therapeutics

The DOI matches its Crossref record.

Abstract

UNLABELLED: Antihistamines and nasal decongestants are well-established therapeutics in allergic rhinitis. However, no data are available which directly compare the effect size of the single substances with their combination in a single study including placebo (PLA) treatment. OBJECTIVE: The aim of this study was to evaluate the effect of a combination of cetirizine (CET) and pseudoephedrine (PSE) and to compare it to treatment with CET or PSE alone and to PLA during grass pollen allergen challenge in an environmental challenge chamber (ECC). MATERIAL AND METHODS: In a randomized, double-blind, placebo-controlled, four-way crossover study the effect of a combination of 10 mg CET with 120 mg PSE (CET + PSE) versus CET or PSE alone or PLA on symptoms, nasal flow, and nasal secretions was investigated in 49 patients with intermittent allergic rhinitis. Subjects underwent four 6-h pollen exposures in an ECC with administration of the drugs after 2 h. RESULTS: The induction of nasal symptoms, nasal secretion and nasal obstruction (measured as nasal flow) during the first 2 h of pollen exposure was highly reproducible at the 4 consecutive exposures. The symptom of nasal obstruction was significantly reduced after treatment with CET + PSE compared to the treatment with CET or PSE alone or PLA (p < 0.0001). Furthermore, the combination treatment significantly reduced the total nasal symptom score (TNSS) and visual analogue scale score (VAS) compared to the single treatments or PLA. Nasal flow was significantly increased after treatment with CET + PSE and PSE and nasal secretions were significantly reduced by CET + PSE and CET without significant additional improvement of the combination therapy. CONCLUSION: The combination treatment with CET and PSE is more effective than treatment with single substances in subjects with allergic rhinitis.

Overview

Integrity signals

Registry

Crossref · 10.5414/cpp47071

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Still being checked.

Cited by

See all 31

Metadata

Authors
Badorrek, P., Dick, M., Schauerte, A., Hecker, H., Murdoch, R., Luettig, B., Hohlfeld, J. M., & Krug, N.
Affiliations
Fraunhofer Institute for Toxicology and Experimental Medicine (DE)
Venue
Int. Journal of Clinical Pharmacology and Therapeutics
Published
2009-02-01
Volume
47
Issue
02
Pages
71-77
ISSN
0946-1965 (ISSN-L)
OpenAlex
W2330868447
Cited by
30
References
0
Citations by year
2025: 3 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2018: 4 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 4 · 2012: 3
FWCI
2.12
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Clinical Pharmacology and Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft) (submittedVersion)
  • Fraunhofer-Publica (Fraunhofer-Gesellschaft) (submittedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
Keywords
allergic rhinitis, cetirizine, pseudoephedrine, combination therapy, antihistamines, nasal decongestants, nasal obstruction, nasal secretions, intermittent allergic rhinitis
MeSH terms
Adult, Double-Blind Method, Drug Combinations, Drug Synergism, Female, Rhinitis, Allergic, Seasonal, Humans, Male, Middle Aged, Pollen, Nasal Decongestants, Nasal Obstruction, Cetirizine, Cross-Over Studies, Histamine H1 Antagonists, Non-Sedating, Pseudoephedrine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis. https://app.cochat.ai/papers/10.5414/cpp47071
The paper
Badorrek, P., Dick, M., Schauerte, A., Hecker, H., Murdoch, R., Luettig, B., Hohlfeld, J. M., & Krug, N. (2009). A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cpp47071

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.